Projects per year
Fingerprint
Dive into the research topics where Division of Molecular Oncology and Hematology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.01.2022 → 31.12.2025
Project: Funded Research
-
APOG: ACCESS POINT Oncology
Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI) & Fossati, P. (PI)
01.01.2020 → 31.12.2024
Project: Funded Research
-
Biomarker: Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI), Podar, K. (CoI) & Wiesner, C. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2019 → 31.12.2023
Project: Funded Research
Research output
-
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
Lind, J., Aksoy, O., Prchal-Murphy, M., Fan, F., Fulciniti, M., Stoiber, D., Bakiri, L., Wagner, E. F., Zwickl-Traxler, E., Sattler, M., Kollmann, K., Vallet, S. & Podar, K., 19 Aug 2024, In: Blood Cancer Journal. 14, 1, 138.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation
Gassner, T., Chittilappilly, C., Pirich, T., Neuditschko, B., Hackner, K., Lind, J., Aksoy, O., Graichen, U., Klee, S., Herzog, F., Wiesner, C., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 03 May 2024, In: Journal for ImmunoTherapy of Cancer. 12, 5, e008669.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional analysis of the randomized AGMT 02 study
Ludwig, H., Melchardt, T., Schweitzer, I., Sormann, S., Schreder, M., Andel, J., Hartmann, B., Zojer, N., Schöffmann, L., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Wöll, E., Ruckser, R., Bozic, B., Krauth, M., Petzer, A., Schmitt, C. & Machherndl‐spandl, S. & 5 others, , Jun 2024, In: eJHaem. 5, 3, p. 494-504 11 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access
Prizes
-
Posterpreis bei OeGHO Kongress
Gassner, T. (Recipient), Apr 2023
Prize: Other distinction › Poster prize
-
Preis für Best Submitted Abstract bei OeGHO Kongress
Aksoy, O. (Recipient), Apr 2023
Prize: Other distinction › Other
-
Wissenschaftspreis des Landes Niederösterreich 2022
Vallet, S. (Recipient), 2022
Prize: Honorary award
Activities
- 3 Membership
-
-
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie (OeGHO) (External organisation)
Vallet, S. (Member)
2022Activity: Membership
-
European Society for Medical Oncology (External organisation)
Vallet, S. (Member)
2022 → …Activity: Membership